IV | 0 (0.0%) | 3 (4.8%) |
|
Aminoglycoside therapy |
|
| 0.561 |
aminoglycoside therapy | 268 (76.4%) | 51 (79.7%) |
|
no aminoglycoside therapy | 83 (23.6%) | 13 (20.3%) |
|
Aminoglycoside therapy duration |
|
| <0.001 |
Mean (SD) | 2.74 (1.74) | 4.63 (2.35) |
|
Median (Q1, Q3) | 2.00 (1.00, 4.00) | 5.00 (3.00, 6.50) |
|
Min - Max | 1.00 - 11.00 | 1.00 - 9.00 |
|